Arvinas
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to targetcertain harmful proteins causing oncology and neurology-related diseases.
公司地址 395 Winchester Avenue, 5 Science Park, New Haven, CT, USA, 06511
電話號碼 +1 203 535-1456
傳真號碼 --
公司網頁 https://www.arvinas.com
員工數量 246
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Noah Berkowitz, M.D.,PhD Chief Medical Officer 美元 421.83K 29/04/2025
Mr. Andrew R. Saik Chief Financial Officer and Treasurer 美元 272.60K 24/02/2026
Mr. David K. Loomis Vice President and Chief Accounting Officer -- 24/02/2026
Dr. Angela Cacace, PhD Chief Scientific Officer 美元 464.75K 29/04/2025
Mr. Randy Teel, PhD Director, President and Chief Executive Officer 美元 475.00K 12/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. John Douglas Young Independent Director 29/04/2025
Ms. Leslie V. Norwalk, Esq. Independent Director 24/02/2026
Dr. Briggs W. Morrison, M.D. Chairman of the Board 12/02/2026
Ms. Linda C. Bain Independent Director 24/02/2026
Dr. Laurie Smaldone Alsup, M.D. Independent Director 24/02/2026
Mr. Randy Teel, PhD Director, President and Chief Executive Officer 12/02/2026
Dr. John G. Houston, PhD Director 12/02/2026
Mr. Edward Kennedy, Jr Independent Director 24/02/2026
Dr. Sunil Agarwal, M.D. Independent Director 24/02/2026
Mr. Everett V. Cunningham Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:48)
代號 名稱 佔比% ▼ 持有日期
ESSCEventide Small Cap ETF0.004%27/02/2026
DXUVDimensional US Vector Equity ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
AVSUAvantis Responsible US Equity ETF0.002%28/02/2026
GUGGuggenheim Active Allocation Fund0.001%30/11/2025
QQQXNuveen NASDAQ 100 Dynamic Overwrite0.0004%30/11/2025
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
BMEDiShares Health Innovation Active ETF0.0003%26/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
AIEQAmplify AI Powered Equity ETF<0.000001%27/02/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF<0.000001%23/06/2025
DFUSDimensional US Equity Market ETF<0.000001%18/02/2026
ESGVVanguard ESG US Stock ETF<0.000001%30/09/2025
ESMLiShares ESG Aware MSCI USA Small-Cap ETF<0.000001%28/02/2026
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%07/10/2025
FYCFirst Trust Small Cap Gr AlphaDEX® ETF<0.000001%07/10/2025
ISCGiShares Morningstar Small-Cap Growth ETF<0.000001%28/02/2026
LQPEPEO AlphaQuest Thematic PE ETF<0.000001%31/07/2025
MNTLTema Neuroscience and Mental Health ETF<0.000001%05/08/2025
RUSCRussell Inv U.S. Small Cap Equity ETF<0.000001%31/01/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.